Fund Holdings — NEA Management Company, LLC

Total Portfolio Value:
$1.36B
Total Bought:
$0
Total Sold:
$111.97M
Net Transaction:
-$111.97M
Notable People:
Anthony Angelo Florence, Mohamad Hassan Makhzoumi
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
MBX Biosciences, Inc.(MBX)3,614,4863,614,4860$199.52M$211.88M15.53%+$12.36M
SpyGlass Pharma, Inc.(SGP)7,392,3017,392,3010$164.55M$192.20M14.09%+$27.65M
Trevi Therapeutics, Inc.(TRVI)13,222,22813,222,2280$246.59M$189.34M13.88%-$57.25M
Celcuity Inc.(CELC)1,710,5611,710,5610$178.96M$136.02M9.97%-$42.94M
Savara Inc.(SVRA)24,471,26424,471,2640$150.74M$126.27M9.26%-$24.47M
Zenas BioPharma, Inc.(ZBIO)4,023,2194,023,2190$102.11M$108.51M7.95%+$6.40M
Monte Rosa Therapeutics, Inc.7,692,2986,692,298-1,000,000$186.15M$79.84M5.85%-$106.31M
Aurinia Pharmaceuticals Inc.(AUPH)3,969,8343,969,8340$67.37M$64.29M4.71%-$3.08M
Coursera, Inc.(COUR)12,867,76912,867,7690$72.57M$63.82M4.68%-$8.75M
CRISPR Therapeutics AGNAMEN AKT(CRSP)1,058,5701,058,5700$57.73M$58.56M4.29%+$825.7K
ORIC Pharmaceuticals, Inc.4,118,6214,118,6210$44.60M$55.48M4.07%+$10.87M
Phathom Pharmaceuticals, Inc.1,960,1691,960,1690$21.27M$14.31M1.05%-$6.96M
Korro Bio, Inc.1,297,8931,297,8930$17.11M$12.86M0.94%-$4.24M
X4 Pharmaceuticals, Inc.3,233,7433,233,7430$15.10M$9.38M0.69%-$5.72M
Nkarta, Inc.3,568,7813,568,7810$10.10M$9.35M0.69%-$749.4K
Champions Oncology, Inc.1,713,7201,713,7200$10.56M$8.57M0.63%-$1.99M
Black Diamond Therapeutics, Inc.4,448,7574,448,7570$8.23M$8.39M0.61%+$155.7K
Inventiva SAADS1,462,5861,462,5860$5.53M$5.40M0.40%-$131.6K
CVRx, Inc.1,954,4401,954,4400$10.05M$3.42M0.25%-$6.63M
Marker Therapeutics, Inc.1,625,6781,625,6780$2.39M$1.74M0.13%-$650.3K
LeonaBio, Inc.464,398464,3980$4.27M$1.66M0.12%-$2.61M
OnKure Therapeutics, Inc.CL A478,548478,5480$2.18M$1.30M0.10%-$878.1K
Senti Biosciences, Inc.
COM NEW
3,775,6153,775,6150$4.15M$1.18M0.09%-$2.97M
ImageneBio, Inc.50,00550,0050$295.0K$229.0K0.02%-$66.0K
Gossamer Bio, Inc.1,000,00012,500-987,500$164.6K$148.1K0.01%-$16.5K
Karyopharm Therapeutics Inc.(KPTI)576,7800-576,780$5.64M$0—-$5.64M
Page 1 of 1
NEA Management Company, LLC — 13F Holdings — Q3 2026 | TickerTrail